Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 1 of 7
`
`UNITED STATES DISTRICT COURT
`SOUTHERN DISTRICT OF NEW YORK
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Aurobindo Pharma Limited and
`Aurobindo Pharma USA Inc.,
`
`Defendants.
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Amneal Pharmaceuticals, LLC,
`
`Defendants.
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Mylan Inc. and Mylan Pharmaceuticals
`Inc.,
`
`Defendants.
`
`Civil Action No. 14-CV-2497 (PAC)
`
`Civil Action No. 14-CV-2758 (PAC)
`
`Civil Action No. 14-CV-2647 (PAC)
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 2 of 7
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Zydus Pharmaceuticals (USA) Inc., and
`Cadila Healthcare Ltd. (dba Zydus Cadila),
`
`Defendants.
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Orient Pharma Co., Ltd.,
`
`Defendants.
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`v.
`
`Sawai USA, Inc., and
`Sawai Pharmaceutical Co., Ltd.,
`
`Defendants.
`
`Civil Action No. 14-CV-2760 (PAC)
`
`Civil Action No. 14-CV-2759 (PAC)
`
`Civil Action No. 14-CV-5575 (PAC)
`
`UNOPPOSED MOTION TO EXTEND DISCOVERY DEADLINE
`
`2
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 3 of 7
`
`Plaintiffs Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc., and Nissan
`
`Chemical Industries, Ltd., respectfully move that the following discovery deadline set forth
`
`under the Civil Case Management Plan and Scheduling Order entered by the Court on October
`
`17, 2014 (see ECF No. 43, in Civil Action No. 14-cv-2497) (“10/17/14 Scheduling Order”) in
`
`the above-captioned actions be modified as follows:
`
`Event
` Markman – jointly file a Joint
`Disputed Claim Terms Chart
`pursuant to Local Patent Rule 11
`
`Current Deadline
`April 6, 2015
`
`Proposed Modified Deadline
`April 10, 2015
`
`No other dates or deadlines set forth in the 10/17/14 Scheduling Order shall be altered by
`
`the present motion. The parties have not previously requested an extension to the foregoing
`
`deadline, and have made one previous request for extension of two dates with regard to the
`
`10/17/14 Scheduling Order, which was granted.
`
`Counsel for all defendants have indicated that they do not oppose the present motion.1/
`
`The present motion is necessitated because counsel for the parties have not yet been able
`
`to agree on a Joint Disputed Claim Terms Chart as required by the schedule. Counsel for the
`
`parties have met and conferred in an attempt to prepare the Chart, but have unable to do so to
`
`date. The time for preparing and filing a Joint Disputed Claim Terms Chart was somewhat
`
`compressed by the extension of the prior two dates,2/ and has been further complicated by the
`
`fact that the date for submission of the Chart was inadvertently set for the day after Easter.
`
`The Apotex case caption is not included in these papers because no Markman issues are in dispute in that
`
`1/
`case.
`2/
`The reason the time was compressed was as a result of plaintiffs’ consent to the defendants' request to file
`the February 27th joint stipulation to move the earlier Markman deadlines to accommodate the defendants’
`scheduling conflicts. Plaintiffs have been trying for days to get the defendants to consent to file a joint stipulation to
`move the date which is the subject of this motion. Despite plaintiffs’ previous cooperation and consent to
`defendants’ previous request to file a joint stipulation, the defendants have refused to join in a corresponding
`stipulation, thus necessitating the present motion.
`
`3
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 4 of 7
`
`The parties are working on scheduling a further meet and confer in an effort to see if any
`
`issues can be resolved.
`
`It is respectfully requested that the Court grant the present motion, and move the date for
`
`filing a Joint Disputed Claim Terms Chart four days, from April 6, 2015 to April 10, 2015.
`
`Dated: April 3, 2015
`
`Respectfully submitted,
`
`s/David G. Conlin
`Jennifer L. Dereka
`MINTZ, LEVIN, COHN, FERRIS,
`GLOVSKY AND POPEO, P.C.
`Chrysler Center
`666 Third Avenue
`New York, NY 10017
`(212) 935-3000
`JLDereka@mintz.com
`
`David G. Conlin (admitted pro hac vice)
`Kathleen B. Carr (admitted pro hac vice)
`Adam P. Samansky
`MINTZ LEVIN COHN FERRIS GLOVSKY
`AND POPEO P.C.
`One Financial Center
`Boston, MA 02111
`(617) 542-6000
`DGConlin@mintz.com
`KBCcarr@mintz.com
`APSamansky@mintz.com
`
`Attorneys for Plaintiffs
`Kowa Company, Ltd.
`Kowa Pharmaceuticals America, Inc. and
`Nissan Chemical Industries, Ltd.
`
`4
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 5 of 7
`
`CERTIFICATE OF SERVICE
`
`I, David G. Conlin, hereby certify that on this 3rd day of April, 2015, I caused to be
`served a true and accurate copy of the foregoing Unopposed Motion to Extend Discovery
`Deadline by first class mail and by email upon:
`
`Constance S. Huttner (chuttner@buddlarner.com)
`Caroline Sun (csun@buddlarner.com)
`BUDD LARNER, PC
`150 John F. Kennedy Parkway
`Short Hills, NJ 07078-2703
`
`Attorneys for Defendant,
`Amneal Pharmaceuticals LLC
`
`H. Keeto Sabharwal (keetos@skgf.com)
`Chandrika Vira (cvira@skgf.com)
`Paul Ainsworth (painsworth@skgf.com)
`STERNE, KESSLER, GOLDSTEIN & FOX, PLLC
`1100 New York Avenue NW
`Washington, D.C. 20005
`
`Attorneys for Defendants
`Aurobindo Pharma Ltd. and
`Aurobindo Pharma USA Inc.
`
`Arnold B. Calmann (abc@saiber.com)
`SAIBER LLC
`One Gateway Center, Suite 1000
`Newark, New Jersey 07102
`
`Jakob B. Halpern (jbh@saiber.com)
`SAIBER LLC
`18 Columbia Turnpike, Suite 200
`Florham Park, NJ 07932
`
`and
`
`5
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 6 of 7
`
`William A. Rakoczy (wrakoczy@rmmslegal.com)
`Deanne M. Mazzochi (dmazzochi@rmmslegal.com)
`Amy D. Brody (abrody@rmmslegal.com)
`Luke T. Shannon (lshannon@rmmslegal.com)
`Natasha L. White (nwhite@rmmslegal.com)
`Thomas R. Burns (tburns@rmmslegal.com)
`William F. Ward (wward@rmmslegal.com)
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`
`Attorneys for Defendants
`Mylan Pharmaceuticals Inc. and Mylan Inc.
`
`Natalie Clayton (natalie.clayton@alston.com)
`Paki Banky (paki.banky@alston.com
`ALSTON & BIRD, LLP
`90 Park Avenue
`New York, NY 10016
`
`Attorney for Defendant
`Orient Pharma Co., Ltd.
`
`Craig S. Kesch (ckesch@fzwz.com)
`FLEMMING ZULACK WILLIAMSON
`ZAUDERER LLP
`One Liberty Plaza
`New York, NY 10006-1404
`
`and
`
`Chidambaram S. Iyer (ciyer@sughrue.com)
`Michael Dzwonczyk (mdzwonczyk@sughrue.com)
`Azy S. Kokabi (akokabi@sughrue.com)
`SUGHRUE MION, PLLC
`2100 Pennsylvania Avenue, NW
`Washington, D.C. 20037
`
`Attorneys for Defendant
`Sawai USA Inc. and Sawai Pharmaceutical Co., Ltd.
`
`6
`
`

`

`Case 1:14-cv-02758-PAC Document 55 Filed 04/03/15 Page 7 of 7
`
`Vincent P. Rao II (vrao@kelleydrye.com)
`KELLEY DRYE & WARREN LLP
`One Jefferson Road, 2nd Floor
`Parsippany, NJ 07054
`
`Steven J. Moore (smoore@kelleydrye.com)
`Elizabeth W. Swedock (eswedock@kelleydrye.com)
`KELLEY DRYE & WARREN LLP
`400 Atlantic Street
`Stamford, CT 06901
`
`Attorneys for Defendants
`Zydus Pharmaceuticals (USA) Inc. and
`Cadila Healthcare Limited
`
`Dated: April 3, 2015
`
`s/David G. Conlin
`David G. Conlin
`
`7
`
`